|
FCHO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.459800E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.221570E-01 |
| Normal-vs-Stage2 |
1.950210E-01 |
| Normal-vs-Stage3 |
5.407400E-01 |
| Normal-vs-Stage4 |
5.384400E-02 |
| Stage1-vs-Stage2 |
5.242600E-01 |
| Stage1-vs-Stage3 |
3.572100E-02 |
| Stage1-vs-Stage4 |
1.751790E-04 |
| Stage2-vs-Stage3 |
1.131610E-01 |
| Stage2-vs-Stage4 |
2.647800E-02 |
| Stage3-vs-Stage4 |
2.658000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.914400E-01 |
| Normal-vs-AfricanAmerican |
4.763000E-01 |
| Normal-vs-Asian |
9.899700E-02 |
| Caucasian-vs-AfricanAmerican |
1.652590E-01 |
| Caucasian-vs-Asian |
3.307400E-01 |
| AfricanAmerican-vs-Asian |
7.327600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.861000E-01 |
| Normal-vs-Female |
9.997600E-01 |
| Male-vs-Female |
3.691000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.232400E-01 |
| Normal-vs-Age(41-60Yrs) |
3.508600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.218000E-01 |
| Normal-vs-Age(81-100Yrs) |
7.728000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.506300E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.222410E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.699400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.023400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.315200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.508600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
8.116400E-02 |
| Normal-vs-Grade 2 |
2.090100E-02 |
| Normal-vs-Grade 3 |
7.875600E-01 |
| Normal-vs-Grade 4 |
1.772350E-04 |
| Grade 1-vs-Grade 2 |
7.310800E-01 |
| Grade 1-vs-Grade 3 |
5.679700E-02 |
| Grade 1-vs-Grade 4 |
1.567120E-04 |
| Grade 2-vs-Grade 3 |
2.981500E-03 |
| Grade 2-vs-Grade 4 |
3.34500005472194E-09 |
| Grade 3-vs-Grade 4 |
2.2540999999987E-05 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.829100E-04 |
| Normal-vs-ccB subtype |
1.094200E-01 |
| ccA subtype-vs-ccB subtype |
4.3187999998473E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.149200E-01 |
| Normal-vs-N1 |
7.019500E-02 |
| N0-vs-N1 |
2.126300E-02 |
|
|
